BioMedNewsBreaks – Odyssey Health Inc. (ODYY) Files for Patent Protection on Novel Breath-Propelled Intranasal Brain-Drug Delivery Device
Nov 1, 2022
Odyssey Health (OTC: ODYY) has filed for United States and global patent protection on its novel breath-propelled, intranasal brain-drug delivery device (“Nasal Device”). As previously announced, Odyssey’s recently completed phase I study to treat concussion successfully used Odyssey’s Nasal Device and drug combination. “We were very pleased with the functionality and performance of the Nasal Device during the phase I study and its administration of Odyssey’s PRV-002 concussion drug,” said Michael Redmond, CEO of Odyssey. “The ability to get drugs for neurological conditions delivered directly into the brain rapidly at effective levels while simultaneously having less concern for side effects is a huge advantage in the development of safe and efficacious treatments. Odyssey’s novel Nasal Device provides that opportunity and advantage.”
To view the full press release, visit https://ibn.fm/1JJOt
About Odyssey Health Inc. (formerly Odyssey Group International Inc.)
Odyssey Health is a medical company with a focus in life-saving products and solutions. Odyssey’s corporate mission is to create, acquire and develop distinct assets, intellectual property and exceptional technologies that provide meaningful medical solutions. The company is focused on areas that have an identified technological advantage, provide superior clinical utility, and have a substantial market opportunity. For more information, visit the company’s website at www.OdysseyHealthInc.com.
NOTE TO INVESTORS: The latest news and updates relating to ODYY are available in the company’s newsroom at https://ibn.fm/ODYY
About BioMedWire
BioMedWire (BMW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) BioMedNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, BMW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. BMW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, BMW brings its clients unparalleled visibility, recognition and brand awareness. BMW is where news, content and information converge.
To receive SMS text alerts from BioMedWire, text “Biotech” to 844-397-5787 (U.S. Mobile Phones Only)
For more information please visit https://www.BioMedWire.com
Please see full terms of use and disclaimers on the BioMedWire website applicable to all content provided by BMW, wherever published or re-published: http://BMW.fm/Disclaimer
BioMedWire (BMW)
San Francisco, California
www.BioMedWire.com
415.949.5050 Office
[email protected]
BioMedWire is part of the InvestorBrandNetwork
More News
Trump Announces $8 Billion Plan to Cover Farm Losses
Under the Harvest Fuel Relief Program, the Agriculture Department will provide economic aid for farmers hurt by high diesel prices.
Google resolves cloud outage affecting UK banks and websites
Revolut was one of the hardest hit, with banking services going down for many customers.
Heading to France? Amid Recent Unrest, Here’s What to Know
Rioting over affordability and public education has swept through Paris and other French cities, and there may be more to come.
UK government to make Jackdaw gas field announcement
The long-awaited decision about the controversial North Sea field is expected on Wednesday morning.
Knicks Ticket Prices Are Soaring After Last Season’s Championship
Knicks tickets have never been cheap, but prices for the first game alone are soaring after last season’s championship — more than a trip to Paris.
Investors in Anticipation Over Musk’s Next Big SpaceX Deal
Ahead of SpaceX’s quarterly earnings report, many on Wall Street are wondering whether Elon Musk will combine it with Tesla.
Paddy Power cuts 1,400 jobs and blames betting tax rises
The government increased taxes on online casino and sports betting in last year's Budget.
Trump Tariffs on Canada Spark Latest Lawsuit Over Trade Powers
Once again, the president’s ability to wage a trade war without Congress will come before a court that has repeatedly ruled against him.
Union attacks NatWest plans to get workers back to the office
The bank says workers will be required to attend the office at least two days a week from February.
A ‘Doom Loop’ Threatens France as Populism Confronts Markets
The turmoil shows the profound challenges facing governments stuck between unhappy citizens and wary bond investors.
Bereaved families could face 'unjust' tax bill after civil service pension delays
The chairman of Parliament's Public Accounts Committee says families should not be taxed through no fault of their own.
Jobless rate falls but small firms cut back hiring
Small firms cite labour costs as a key factor in scaling back hiring, the Office for National Statistics says.
YOUR NEWS, OUR NETWORK.
Do you have Great News you want to tell the world?
Be it updates about your business or your community, you can make sure that it’s heard by submitting your story to our network reaching hundreds of news sites across 6 verticals.